2021
DOI: 10.3390/neurolint13030034
|View full text |Cite
|
Sign up to set email alerts
|

Cognitive Dysfunction in Multiple Sclerosis: Educational Level as a Protective Factor

Abstract: Most people with MS experience cognitive deficits especially in attention, memory, information processing, and executive functions, negatively impacting on their quality of life. Cognitive variables of short-term memory, logical memory, and verbal fluency in 65 patients with multiple sclerosis (MS) were analysed in conjunction with sociodemographic variables such as sex, age, and educational level that might influence disease progression. We found that psychoeducational variables exerted a significant effect o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Additionally, given the multiplicity of variables that may play a role in noncredible presentations (e.g., psychiatric symptomatology, presence of secondary gain), future research is strongly encouraged to parse out the relevant dimensions that may meaningfully contribute to and/or explain noncredible performance on cognitive tests. Finally, while differences in gender and years of education between credible and noncredible groups were not considered to be clinically meaningful in this study (as is consistent with prior research with similar aims) [45][46][47], future work may seek to consider the impact of baseline patient characteristics on neuropsychological test scores and, by extension, performance validity in pwMS, as some have suggested that level of education and/or disease subtype may differentially influence aspects of test performance in MS [63].…”
Section: Limitationsmentioning
confidence: 59%
“…Additionally, given the multiplicity of variables that may play a role in noncredible presentations (e.g., psychiatric symptomatology, presence of secondary gain), future research is strongly encouraged to parse out the relevant dimensions that may meaningfully contribute to and/or explain noncredible performance on cognitive tests. Finally, while differences in gender and years of education between credible and noncredible groups were not considered to be clinically meaningful in this study (as is consistent with prior research with similar aims) [45][46][47], future work may seek to consider the impact of baseline patient characteristics on neuropsychological test scores and, by extension, performance validity in pwMS, as some have suggested that level of education and/or disease subtype may differentially influence aspects of test performance in MS [63].…”
Section: Limitationsmentioning
confidence: 59%
“…Moreover, Alzheimer's disease (AD) patients with CR proxies can show more advanced AD-type neuropathology but comparable clinical severity of cognitive impairment than those without CR proxies [2,4]. Studies have reported similar findings in different neurodegenerative diseases such as multiple sclerosis [5], Parkinson's disease [6], and schizophrenia [7]. Therefore, there is an increasing interest in developing interventions capable of fostering CR in the treatment of cognitive decline.…”
Section: Introductionmentioning
confidence: 99%